Fennec Pharmaceuticals (NASDAQ:FENC) Earns “Buy” Rating from HC Wainwright
Fennec Pharmaceuticals (NASDAQ:FENC – Get Free Report)‘s stock had its “buy” rating reissued by analysts at HC Wainwright in a research report issued on Tuesday,Benzinga reports. They presently have a $13.00 price target on the stock. HC Wainwright’s target price suggests a potential upside of 100.00% from the stock’s previous close. FENC has been the […]
Fennec Pharmaceuticals (NASDAQ:FENC – Get Free Report)‘s stock had its “buy” rating reissued by analysts at HC Wainwright in a research report issued on Tuesday,Benzinga reports. They presently have a $13.00 price target on the stock. HC Wainwright’s target price suggests a potential upside of 100.00% from the stock’s previous close. FENC has been the […]
